Design
Editorial
Authors
Loading...
The authors argue that rapid and widespread delivery of any thrombolytic agent is more clinically important than the small differences in efficacy or safety between specific regimens.
Key points are not available for this paper at this time.
Paul M. Ridker (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: